|
Publication |
|
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer. Taprogge J, Murray I, Sharman H, Gape P, Leek F, Abreu C, Vávrová L, Newbold K, Wong KH, Luster M, Verburg FA, Schurrat T, Vija L, Courbon F, Vallot D, Bardiès M, Schumann S, Eberlein U, Lassmann M, Flux G. Eur Thyroid J. 2025 Jul 1;14(4):e250097. doi: 10.1530/ETJ-25-0097. Print 2025 Aug 1.
|
|
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project. Taprogge J, Vergara-Gil A, Leek F, Abreu C, Vávrová L, Carnegie-Peake L, Schumann S, Eberlein U, Lassmann M, Schurrat T, Luster M, Verburg FA, Vallot D, Vija L, Courbon F, Newbold K, Bardiès M, Flux G. Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3225-3234. doi: 10.1007/s00259-023-06295-0. Epub 2023 Jun 10.
|
|
Initial results of the INSPIRE clinical trial-investigating radiation dosimetry for differentiated thyroid cancer patients. Taprogge J, Abreu C, Vávrová L, Carnegie-Peake L, Rushforth D, Gape P, Gear J, Murray I, Wong KH, Newbold K, Yusuf S, Flux G. Front Nucl Med. 2023 May 15;3:964478. doi: 10.3389/fnume.2023.964478. eCollection 2023.
|
|
Strain differences in intraluminal thread model of middle cerebral artery occlusion in rats. Svoboda J, Litvinec A, Kala D, Pošusta A, Vávrová L, Jiruška P, Otáhal J. Physiol Res. 2019 Mar 6;68(1):37-48. doi: 10.33549/physiolres.933958. Epub 2018 Oct 23.
|
|
| | Last update Publications 07.07.2025 |
|